Brian Kobilka | |
---|---|
Born | Brian Kent Kobilka May 30, 1955 Little Falls, Minnesota, United States |
Nationality | American |
Fields | Crystallography |
Institutions | Stanford University, Duke University |
Alma mater | University of Minnesota Duluth, Yale University |
Academic advisors | Robert Lefkowitz |
Notable awards | Nobel Prize in Chemistry (2012) |
Brian Kent Kobilka (born May 30, 1955) is an American physiologist and a recipient of the 2012 Nobel Prize in Chemistry with Robert Lefkowitz for discoveries that reveal the inner workings of an important family G protein-coupled receptors. He is currently a professor in the department of Molecular and Cellular Physiology at Stanford University School of Medicine. He is also the co-founder of ConfometRx, a biotechnology company focusing on G protein-coupled receptors. He was named a member of the National Academy of Sciences in 2011.
Kobilka, a Roman Catholic, attended St. Mary's Grade School in Little Falls, Minnesota, a part of the Roman Catholic Diocese of Saint Cloud. He then Graduated from Little Falls High School. He received a Bachelor’s Degree in Biology and Chemistry from the University of Minnesota Duluth, and earned his M.D., cum laude, from Yale University School of Medicine. Following the completion of his residency in internal medicine at Barnes-Jewish Hospital in St. Louis, Missouri, Kobilka worked in research as a postdoctoral fellow under Robert Lefkowitz at Duke University, where he started work on cloning the β2-adrenergic receptor. Kobilka moved to Stanford in 1989. He was a Howard Hughes Medical Institute (HHMI) investigator from 1987-2003.